Despite their histological resemblance to colorectal adenocarcinoma, there is little information on the molecular events involved in the pathogenesis of intestinal-type sinonasal adenocarcinoma (ITACs). The aim of this paper is to evaluate the possible role of TP53 and BcI-2 gene defects in ITAC by investigating the immunohistochemical expression of TP53 and Bcl-2 gene products in a group of ethmoidal ITACs associated with occupational exposure. A retrospective study on 15 patients with pathological diagnosis of primary ethmoidal ITAC was conducted. Representative formalin-fixed, paraffin wax-embedded block from each case was selected for immunohistochemical studies using the antibodies against p53 and BcI-2. Clinical-pathological data were also correlated with the staining results. The results of immunohistochemical examination demonstrated that poorly differentiated cases showed a higher percentage of p53 and BcI-2 expressing cells in comparison to well-differentiated cases. No correlation was found with other clinico-pathological parameters, including T, stage and relapses. The relationship between up-regulation of p53 and BcI-2 and poorly differentiated ethmoidal adenocarcinoma suggests a role of these genes, in combination with additional genetic events, in the pathogenesis of ITAC.
Malignant neoplasms of the nasal cavity and parana sal sinuses account for 0.2% of all human primary malignant neoplasms with an incidence of 0.1-1.4 new cases/year/IOO,OOO inhabitants (1-2).
Adenocarcinomas account for 10-20% of all primary malignant neoplasms of the sinonasal tract (3) . Many of these are of salivary gland origin, but others have histologic patterns similar to those of adenocarcinoma of the colon. These latter ones have been named intestinal-type adenocarcinoma (ITAC) and are responsible for less than 4% of the total malignancies of this region (4) . Intestinaltype adenocarcinoma (ITACs) of the nasal cavity and paranasal sinuses can occur sporadically or are associated with occupational exposure to hardwood and leather dusts (5) . Exposure to wood and leather dust increase the risk of adenocarcinoma 500-fold (6) (7) . Findings from some studies have suggested clinical differences between ITAC arising in individuals with occupational dust exposure and ITAC arising sporadically. Tumors related to occupational exposure affect men in 85-90% of cases, and the tumors show a strong tendency to arise in the ethmoid sinuses (8) (9) (10) .
ITACs are aggressive tumors characterized by frequent local recurrences, low incidence of distant metastases, and an overall mortal ity ofapproximately 53% (10) . Histopathological grading appears to be a significant prognostic indicator (9) (10) (11) . Surgery is considered the standard treatment.
ITAC seems to follow intestinal metaplasia of the respiratory mucosa, induced by hardwood dust. leather dust, and other unknown agents, which is accompanied by a switch to an intestinal phenotype. The molecular mechanisms involved in metaplastic transformation of terminally differentiated epithelium to a phenotypically different epithelium are largely unknown.
The morphological appearance of these tumors is variable and they may resemble conventional colorectal adenocarcinoma. The similarities between lTAC and intestinal adenocarcinoma involve their ultrastructural and immunohistochemical aspects (12) (13) (14) (15) .
Numerous studies have shown that mutations of the K-ras and TP53 genes are common in colorectal adenocarcinomas (16) (17) . In comparison, there is very little information about the molecular events involved in the pathogenesis ofITAC (14, (17) (18) (19) (20) (21) (22) .
To gain further insight into the phenotype and possible mechanisms of sinonasal ITACs, we investigated the expression of p53 and BCL-2 oncoproteins in a group of ethmoidal lTACs associated with occupational exposure.
TP53 is the most frequently studied tumor suppressor gene in head and neck squamous cell carcinoma (HNSCC). Previous studies reported that p53 abnormal action, due to its altered expression or to a mutation in its gene, is a very common event in human cancer. In particular, immunohystochemical and molecular analyses showed that in HSNCC the frequency of its overexpression is between 50-80%. However, the contrasting data on p53 expression in HSNCC do not allow us to use it as clinical prognostic factor (23) .
BcI-2 oncogene, located on chromosome 18q21, is involved in cell cycle and precisely in apoptosis. Several data showed its direct involvement in cancer biological behavior (24) . Even if its overexpression seems to give a selective advantage to altered cells, as it blocks the apoptosis, in literature the studies that associate this role to the tumor prognosis are poor and discordant. According to some of these studies the overexpression is associated with a worse prognosis, for others it has a positive influence (25) (26) (27) (28) (29) .
MATERIALS AND METHODS

Patient selection
The samples of 15 primary ethmoidal intestinal-type adenocarcinomas, were retrospectively retrieved from the archives of the Institute of Pathology. Polytechnic University of Marche, Ancona, Italy.
All the tumors in which the diagnosis of ITAC was confirmed were subsequently subtyped, as papillary. colonic, solid, mixed, or mucinous types, as described by Barnes (2) .
The medical records of these patients were reviewed. Inclusion criteria were complete clinical data, uniformity of histological differentiation throughout the tumor sample, and the availability of sufficient material from the primary tumor for investigations. Patients with previous or synchronous second malignancies or with previous radiation therapy or chemotherapy were excluded from the study.
The follow-up time ranged from 2 to 10 years (mean, 4.8 years).
Immunohistochemistry
Four-micrometer serial sections from formalin-fixed. paraffin-embedded blocks of tumor representative areas were cut for each case.
Immunohistochemical staining for p53 protein was performed using the following antigen retrieval system. Sections were deparaffinized in two changes of xylene for 10 minutes each and then were rehydrated through graded alcohols and immersed in 0.3% hydrogen peroxide in methanol for 30 minutes to block endogenous peroxidase activity. Sections were then washed in PBS. The tissue sections were placed in a microwave oven (Philips, Cooktyronic M720, 700W) in a plastic Coplin jar filled with 10 mM sodium citrate buffer (pH 6.0) at 5 minutes interval, the fluid level in the Coplin jar was removed from the microwave oven and allowed to cool. Slides were incubated overnight with a I:50 dilution of the primary mouse anti-human p53 monoclonal antibody (Dako 00-7. Glostrup, Denmark). A biotin-streptavidin detection system was used with diaminobenzidine as the chromogen. Slides were washed twice with PBS and incubated with the linking reagent (biotinylated antiimmunoglobulins) for 15 minutes, at room temperature. After rinsing in PBS, the slides were incubated with the peroxidase-conjugated streptavidin label for 15 minutes at room temperature. The sections were again rinsed in PBS and incubated with diaminobenzidine for 10 minutes, in the dark. After chromogen development, slides were washed in two changes of water and counterstained with a I: I0 dilution of haematoxylin. The sections were then dehydrated, cleared in xylene, and mounted.
p53 expression and location were evaluated on histological section using a Leitz Orthoplan microscope equipped with a X 400 objective. The percentage of p53 positive cells was evaluated from a minimum of 1,000 cells in each case. Only nuclear staining of epithelial cells was observed, and the nuclei with a clear brown color, regardless of staining intensity, were regarded as p53 positive.
Immunohistochemical staining for bcl-2 was performed by using the standard avidin-biotin-peroxidase complex (ABC) method.
Briefly, each 4-f.lm tissue section was deparaffinized, rehydrated, and incubated with fresh 0.3% hydrogen peroxide in methanol for 30 minutes at room temperature. After rehydratation through a graded ethanol series, the sections for p53 were microwaved in zinc sulphate heptahydrate buffer at 90°C for 10 minutes and then cooled to 30°e.
After incubation with normal goat serum for KAI-I slides, the tissue sections were applied for 30 minutes and removed by blotting. The sections were then incubated with anti-polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at a dilution of I :80 in phosphate-buffered saline (PBS) containing 1% bovine serum albumin at 4°C overnight, washed in PBS, and incubated with secondary antibody for 30 minutes at room temperature. Immunohistochemistry was performed using ABC system (Vectastain; Vector Laboratories, Burlingame, CA, USA). The chromogen was 3,3'diaminobenzidine tetrahydrochloride applied as a 0.02% solution containing 0.0055% H202 in 50 mM ammonium acetate-citric acid buffer (pH 6.0). The sections were lightly counterstained with haematoxylin.
A negative control for p53 immunostaining was performed in all cases by omitting the primary antibody, which, in all instances, resulted in negative immunoreactivity.
The positive control consisted of staining a human normal mammary gland epithelium.
A negative control for BcI-2 immunostaining was performed in all cases by omitting the primary antibody and no detectable staining was evident. The positive control for BcI-2 immunostaining consisted of staining cell membrane of leukocytes.
Scoring ofpreparations
Both the histological diagnoses and evaluation of the immunohistochemical reactions were carried out by two independent observers. Immunohistochemical labeling for both p53 and BcI-2 was classified as positive when more than 5% of nuclei or cells were stained.
Statistical analysis
The following pathological and clinical parameters were analyzed: tumor grade ofdifferentiation (G I,G2,G3), level of infiltration (TI,T2,T3,T4), tumor stage (I, II, III, IV), BcI-2 and p53 immunoreactivity. Differences in BcI-2 and p53 immunoreactivity between the different groups were compared by the non-parametric Kruskal-Wallis test. Statistical significance was set at p<0.05. All statistical analyses were performed using the SPSS statistical package (SPPS Inc. Chicago, IL).
RESULTS
Clinical findings
There were 14 males and 1 female, with a mean age of60.3 years (range 54-74), ofwhom 6 had grade 1,6 had grade II and 3 had grade III adenocarcinomas. One patient was in stage I, 4 patients were in stage II, and 10 patients were in stage III. Clinicopathological staging was determined by the TNM classification (UICC 2009).
All the patients had a known history of occupational exposure to hardwood dust and the intestinal-type adenocarcinoma was localized in all cases in the ethmoid region as confirmed by endoscopic and imaging (TC and/or MRI) evaluation.
The main clinicopathologic features of the patients and the oncoprotein expression are summarized in Table I .
Immunohistochemistry
The cases classified as ITAC showed a variable cellular appearance and were composed of a mixture of tall columnar absorptive cells, atypical stratified cylindrical cells similar to the cells seen in conventional colorectal adenocarcinoma, goblet cells, and large round to polygonal non-descriptive epithelial cells.
p53 and BcI-2 expression
The percentage ofneoplastic cells immunoreactive for p53 ranged from 1 to 90%. In all cases p53 T3  T3   Tl   T3  T3  T3  T3   T2   T3  T2  T2   T3  T3   T3 The percentage of neoplastic cells immunoreactive for BcI-2 ranged from 8 to 60%. In all cases a cytoplasmic immunoreactivity was observed. Also for BcI-2 poorly differentiated cases showed a higher percentage of positive cells in comparison to well-differentiated adenocarcinomas. No correlation between BcI-2 expression and other c1inico-pathological parameters, including T, stage and relapses was found.
DISCUSSION
Despite their histological similarity to colorectal carcinomas, there is very little information about the molecular events involved in the pathogenesis of ITAC. Several crucial pathways of tumorigenesis have been identified in colorectal adenocarcinomas (16) (17) . These pathways involve the mutation and inactivation ofmultiple oncogenes, tumor suppressor genes, and DNA mismatch repair genes including K-Ras, APC, p53, MLH 1, and MSH2 (16) (17) 30) .
Working on the hypothesis that morphological similarities to colorectal adenocarcinomas might reflect equivalent genetic alterations, several authors have investigated the presence of mutations of Ras oncogenes and TP53 in ITAC (18) (19) (20) (21) . TP53 mutations were found in 18-44% of mostly occupational ITACs, whereas, K-Ras mutations were found in 10-15% of ITACs (18) (19) (20) (21) . The results of these studies suggest that mutations of K-Ras and other Ras genes are relatively uncommon in ITAC and similarly, TP53 mutations in ITACs have not been widely demonstrated. In particular, Wu et al. found TP53 mutations in only two of 11 cases investigated (20) . More recently Perrone et al. found TP53 mutations in eight of 20 cases of mostly occupational ITACs (21) . Other studies have shown that K-Ras mutation and C-erb-2 expression could be associated to more aggressive ITACs (14, 22) . Licitra et al. found the existence of two genetic ITACs subgroups, defined by differences in TP53 mutational status or protein functionality, that 
. Figure showing the relationship between histological grade and over-expression of p53 and Bcl-2: A) Poorly differentiated cases showed a higher percentage of Bcl-2 expressing cells in comparison to well differentiated adenocarcinomas; B) Higher percentage ofp53 expressing cells in poor differentiated adenocarcinomas in comparison to well differentiated ones.
strongly influence pathologic response to primary chemotherapy and, ultimately, prognosis (31).
Perez-Ordonez et al. (32) , evaluated the possible role of DNA mismatch repair (MMR) gene defects or disruptions of the Escadherin/Bccatenin complex in ITAC by investigating the immunohistochemical expression of the MMR gene products, E-cadherin and p-catenin in a group of sporadic ITACs; the preserved nuclear expression of MLH 1, MSH2, MSH3, and MSH6 suggested that mutations or promoter methylation of MMR genes do not playa role in the pathogenesis of ITAC.
Kennedy et al. (33) , found that sinonasal ITACs have a distinctive phenotype, with all cases expressing CK20, CDX-2, and villin and most ITACs also expressing CK7, so that the expression pattern of CK7, CK20, CDX-2, and villin positive may be useful in separating these tumors from other non-ITAC adenocarcinomas of the sinonasal tract.
Given these findings, to explore other pathways involved in the molecular pathogenesis of ITACs, we immunohistochemically investigated the expression of the apoptosis-regulating protein p53, BcI-2 in a group of 15 ethmoidal ITAC associated with occupational exposure. There are no previous reports on the expression of BcI-2 proteins in ITACs.
These immunohistochemical expressions were also retrospectively correlated with the patient outcome to evaluate their independent prognostic relevance.
The results of our immunohistochemical examination showed a relationship between p53 and BcI-2 over-expression and the increase of the histological grading. No correlation was found with other clinico-pathological parameters, including T, stage and relapses.
Our results may therefore suggest that mutations or promoter methylation of TP53 and BcI-2 gene expression could play a role in the pathogenesis of ITAC in combination with additional genetic events.
However, this study showed that p53 and BcI-2 protein expression cannot be considered as an independent prognostic factor in patients with ITACs because, due to the low frequency of mutations, there was not sufficient statistical power to detect statistically significant associations between immunohistochemical expression of these proteins and the clinico-pathologic parameters of the tumors.
